Zobrazeno 1 - 10
of 160
pro vyhledávání: '"E. Jaso"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Juan C. Cancino-Diaz, Sandra Rodríguez-Martínez, Marcos E. Jaso-Vera, Mario E. Cancino-Diaz, Janet Jan-Roblero, María Dolores Alcántar-Curiel, Elizabeth García-Gómez, Humberto Peralta, Gabriel Betanzos-Cabrera, Marco A. Juárez-Verdayes, Juan Carlos Zenteno
Publikováno v:
Microbial Pathogenesis. 103:139-148
In the Staphylococcus aureus ATCC25923 strain, the flqB mutation in the 5′untranslated region (5′UTR) of the norA gene causes increased norA mRNA expression and high efflux activity (HEA). The involvement of the norA gene 5′UTR in HEA has not b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5ea83b1da4e4f9d9d51456e8fda9475
https://doi.org/10.1016/j.micpath.2016.12.021
https://doi.org/10.1016/j.micpath.2016.12.021
Autor:
Daniel D. Shapiro, Jose A. Karam, Logan Zemp, Viraj A. Master, Wade J. Sexton, Ali Ghasemzadeh, Benjamin N. Schmeusser, Facundo Davaro, Taylor Peak, Dattatraya Patil, Surena Matin, Philippe E. Spiess, E. Jason Abel
Publikováno v:
European Urology Open Science, Vol 50, Iss , Pp 43-46 (2023)
Patients with metastatic renal cell cancer (mRCC) who respond to upfront immune checkpoint inhibitor (ICI) combination therapies may be treated with cytoreductive nephrectomy (CN) to remove radiographically viable primary tumors. Early data for post-
Externí odkaz:
https://doaj.org/article/1e2ed9e25a3348a2bc31c993f9a5fb19
Autor:
Ali Ghasemzadeh, Eric T. Wendt, Brendan Dolan, Juliana Craig, Glenn O. Allen, E. Jason Abel, Daniel D. Shapiro
Publikováno v:
Frontiers in Urology, Vol 3 (2023)
ObjectiveTo describe the treatment and outcomes of patients who are medically immunosuppressed due to prior organ transplantation or autoimmune disease with clinical T1 renal cell carcinoma (cT1).MethodsAn institutional database of patients treated f
Externí odkaz:
https://doaj.org/article/289fcbfcce6948e39f0a1bfb18ca804f
Publikováno v:
Société Internationale d’Urologie Journal, Vol 3, Iss 6, Pp 451-463 (2022)
Renal cell carcinoma (RCC) has a natural tendency to invade the venous system with formation of a venous tumor thrombus in the renal vein, which can extend proximally into the inferior vena cava (IVC) and in some cases into the right atrium. The pres
Externí odkaz:
https://doaj.org/article/2e6a46b89e4147c0a1fc6fdb048aa947
Autor:
Moon Hee Lee, Kyung Sung, David Beebe, Wei Huang, Dan Shapiro, Shigeki Miyamoto, E. Jason Abel
Publikováno v:
Oncogenesis, Vol 11, Iss 1, Pp 1-9 (2022)
Abstract While an important role for the SUMO protease SENP1 is recognized in multiple solid cancers, its role in renal cell carcinoma (RCC) pathogenesis, particularly the most dominant subtype, clear cell RCC (ccRCC), is poorly understood. Here we s
Externí odkaz:
https://doaj.org/article/5ee96a81e3a44b89bac3dc2f5661c0ee
Autor:
Elizabeth, García-Gómez, Marcos E, Jaso-Vera, Marco A, Juárez-Verdayes, María D, Alcántar-Curiel, Juan C, Zenteno, Gabriel, Betanzos-Cabrera, Humberto, Peralta, Sandra, Rodríguez-Martínez, Mario E, Cancino-Díaz, Janet, Jan-Roblero, Juan C, Cancino-Diaz
Publikováno v:
Microbial pathogenesis. 103
In the Staphylococcus aureus ATCC25923 strain, the flqB mutation in the 5'untranslated region (5'UTR) of the norA gene causes increased norA mRNA expression and high efflux activity (HEA). The involvement of the norA gene 5'UTR in HEA has not been ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b0f6941545580d9d94dd425660972730
https://pubmed.ncbi.nlm.nih.gov/28017900
https://pubmed.ncbi.nlm.nih.gov/28017900
Autor:
Rory M. Bade, Jennifer L. Schehr, Hamid Emamekhoo, Benjamin K. Gibbs, Tamara S. Rodems, Matthew C. Mannino, Joshua A. Desotelle, Erika Heninger, Charlotte N. Stahlfeld, Jamie M. Sperger, Anupama Singh, Serena K. Wolfe, David J. Niles, Waddah Arafat, John A. Steinharter, E. Jason Abel, David J. Beebe, Xiao X. Wei, Rana R. McKay, Toni K. Choueri, Joshua M. Lang
Publikováno v:
Molecular Oncology, Vol 15, Iss 9, Pp 2330-2344 (2021)
Although therapeutic options for patients with advanced renal cell carcinoma (RCC) have increased in the past decade, no biomarkers are yet available for patient stratification or evaluation of therapy resistance. Given the dynamic and heterogeneous
Externí odkaz:
https://doaj.org/article/e1c2e50d818746e18a79e0890de7a105